ArticleJournal of cardiovascular pharmacology2025
Comparative LDL-C Lowering Efficacy of Nonstatin Therapies: Inclisiran Is Better Than Ezetimibe, PCSK9 Inhibitors, and Bempedoic Acid.
Gaetano Santulli et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this paperpooled itcites it